{
    "nctId": "NCT01031030",
    "briefTitle": "Cyclophosphamide, Methotrexate, and Fluorouracil, With or Without Epirubicin Hydrochloride, in Treating Women Who Have Undergone Surgery for Breast Cancer (Group III Closed to New Patients as of 12/7/2009)",
    "officialTitle": "Adjuvant Treatment of Biologically Aggressive Breast Cancer (N-,N+1,3): Controlled Clinical Study",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 800,
    "primaryOutcomeMeasure": "Overall survival",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Histologically confirmed breast cancer\n\n  * Underwent radical mastectomy, guadrantectomy, or tumorectomy with axillary node dissection within the past 4-6 weeks\n  * Biologically aggressive disease\n  * At least 10 lymph nodes removed\n\n    * Node-negative (\\> 1 cm, or \\> 2 cm if histology is favorable, esp. tubular carcinoma and/or prevalent intraductal component \\> 50%) tumors OR node-positive (1-3) tumors, meeting the following criteria:\n\n      * High thymidine-labeling index (\\> 3%)\n      * Poorly differentiated tumor (grade III)\n      * High S-phase fraction (\\> 10% by flow cytometry)\n      * High Ki67/MIB1 expression (\\< 20%)\n* No bilateral breast cancer\n* No T4a, inoperable T4b, T4c, or T4d disease\n* Any estrogen receptor status (positive, negative, unknown)\n* No distant metastases\n\nPATIENT CHARACTERISTICS:\n\n* Any menopause status\n* WBC \u2265 3,500/mL\n* ANC \u2265 1,500/mL\n* Platelet count \u2265 120,000/mL\n* AST and ALT \u2264 1.5 times upper limit of normal (ULN)\n* Creatinine \u2264 1.5 mg/mL\n* Bilirubin \u2264 1.5 times ULN\n* Not pregnant\n* Geographically accessible for follow-up\n* No prior breast cancer and/or other cancer except for carcinoma in situ of the cervix or basal cell skin cancer treated with radical intent\n* No significant alterations in cardiovascular function\n* No serious psychiatric disorders\n* No impaired renal or liver function\n\nPRIOR CONCURRENT THERAPY:\n\n* See Disease Characteristics",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}